Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,129 | 438 | 96.7% |
| Education | $256.49 | 5 | 3.1% |
| Consulting Fee | $18.50 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,455 | 177 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $708.31 | 41 | $0 (2024) |
| Gilead Sciences, Inc. | $701.45 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $691.49 | 32 | $0 (2024) |
| Celgene Corporation | $509.04 | 27 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $227.16 | 12 | $0 (2024) |
| GENZYME CORPORATION | $217.81 | 8 | $0 (2024) |
| Boston Scientific Corporation | $195.32 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $172.14 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $171.95 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,240 | 57 | ABBVIE INC. ($531.43) |
| 2023 | $1,221 | 67 | ABBVIE INC. ($463.60) |
| 2022 | $1,548 | 88 | ABBVIE INC. ($723.04) |
| 2021 | $1,662 | 93 | AbbVie Inc. ($727.04) |
| 2020 | $660.47 | 31 | AbbVie Inc. ($345.64) |
| 2019 | $707.89 | 40 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($211.93) |
| 2018 | $649.87 | 32 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($218.93) |
| 2017 | $715.69 | 36 | AbbVie, Inc. ($316.37) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.76 | General |
| 12/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: LIVER DISEASE | ||||||
| 09/06/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.30 | General |
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Immunology | ||||||
| 07/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Immunology | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $118.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: VIROLOGY | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 985 | 1,016 | $588,787 | $124,991 |
| 2022 | 13 | 1,054 | 1,260 | $603,753 | $122,016 |
| 2021 | 16 | 1,401 | 1,810 | $689,136 | $155,896 |
| 2020 | 15 | 1,474 | 1,934 | $675,217 | $161,339 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 212 | 212 | $227,688 | $47,793 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 140 | $28,700 | $14,182 | 49.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 168 | 168 | $136,080 | $13,756 | 10.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 155 | 158 | $85,636 | $12,752 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $25,994 | $9,865 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 87 | 87 | $17,835 | $7,175 | 40.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 37 | $27,232 | $7,048 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 88 | $11,968 | $5,806 | 48.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $15,666 | $3,683 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,356 | $1,597 | 36.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,632 | $1,334 | 17.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 215 | 219 | $235,206 | $48,087 | 20.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 162 | 163 | $132,030 | $12,224 | 9.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 125 | 132 | $72,202 | $9,705 | 13.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 121 | 121 | $24,844 | $9,593 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $23,141 | $8,809 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 79 | $16,307 | $7,585 | 46.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 113 | 282 | $35,750 | $7,010 | 19.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 29 | 29 | $21,344 | $5,707 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 69 | $9,384 | $4,343 | 46.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 22 | $16,412 | $4,062 | 24.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 36 | 43 | $7,261 | $3,088 | 42.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 12 | 12 | $7,632 | $1,214 | 15.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $2,240 | $588.91 | 26.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 190 | 194 | $208,356 | $41,861 | 20.1% |
About Dr. Ramesh Koka, M.D
Dr. Ramesh Koka, M.D is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528185162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Koka, M.D has received a total of $8,404 in payments from pharmaceutical and medical device companies, with $1,240 received in 2024. These payments were reported across 444 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,129).
As a Medicare-enrolled provider, Koka has provided services to 4,914 Medicare beneficiaries, totaling 6,020 services with total Medicare billing of $564,243. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Myers, FL
- Active Since 03/26/2007
- Last Updated 11/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1528185162
Products in Payments
- XIFAXAN (Drug) $693.03
- HUMIRA (Biological) $594.09
- CREON (Drug) $567.69
- RINVOQ (Biological) $552.96
- ZEPOSIA (Drug) $525.34
- STELARA (Biological) $454.09
- LINZESS (Drug) $448.28
- SKYRIZI (Biological) $303.50
- DUPIXENT (Biological) $263.41
- MAVYRET (Drug) $251.97
- Humira (Biological) $230.25
- GATTEX (Drug) $206.08
- Linzess (Drug) $190.37
- Mavyret (Drug) $176.02
- Viekira (Drug) $138.87
- EXALT (Device) $121.28
- REMICADE (Biological) $121.06
- XELJANZ (Drug) $120.42
- Penumbra System (Device) $120.00
- ZEPATIER (Drug) $117.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
David Elliott, Do, DO
Gastroenterology — Payments: $8,680